Effect of Secukinumab in the Treatment of Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload
- Status
- UNKNOWN
- Phase
- N/A
EFFORT Further Extension Study
- Status
- UNKNOWN
- Phase
- PHASE4
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
- Status
- RECRUITING
- Phase
- N/A
Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls
- Status
- COMPLETED
- Phase
- NA
Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
- Status
- UNKNOWN
- Phase
- PHASE4
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
- Status
- TERMINATED
- Phase
- PHASE4
SOM230 Ectopic ACTH-producing Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
Pasireotide Treatment for Neuroendocrine Tumor
- Status
- WITHDRAWN
- Phase
- PHASE4
Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors
- Status
- UNKNOWN
- Phase
- PHASE4
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk
- Status
- COMPLETED
- Phase
- NA
Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Cytokeratin 8 Level in Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- N/A
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2